The World Health Organization has released comprehensive guidelines for the clinical management of filovirus disease, including Ebola and Marburg disease.
Key facts
- •The WHO has released comprehensive guidelines for the clinical management of filovirus disease.
- •The guidelines outline 16 evidence-based recommendations for patient care.
- •Ebola and Marburg diseases have case fatality rates ranging from 25% to 90%.
- •There have been 72 outbreaks of Ebola and Marburg diseases reported in Africa since 1967.
- •Early supportive care significantly improves survival in the absence of licensed vaccines and treatments.
- •The guidelines aim to support frontline health workers in providing high-quality care.
The World Health Organization (WHO) has released its first comprehensive guidelines for the clinical management of filovirus disease, which includes all types of Ebola and Marburg viruses. The guidelines highlight the importance of early supportive care to improve patient survival and health outcomes. The release comes as the Democratic Republic of the Congo battles an Ebola disease outbreak caused by the Bundibugyo virus.
By the numbers
Guidelines and Recommendations
The new guidelines outline 16 evidence-based recommendations for the clinical management of filovirus disease. They aim to support frontline health workers in identifying clinical deterioration, managing dehydration and shock, improving patient monitoring, delivering critical supportive interventions safely, and providing structured follow-up for patients who recovered from Ebola and Marburg diseases. The guidelines also emphasize the importance of early recognition, rapid referral, and optimized supportive care for Bundibugyo virus disease.
Importance and Impact
Ebola and Marburg diseases are serious and often fatal, with case fatality rates ranging from 25% to 90% in the most severe outbreaks. There have been 72 outbreaks of Ebola and Marburg diseases reported in Africa since 1967. The outbreaks often have significant socio-economic and psychological impact on communities affected. In the absence of licensed vaccines and treatments for Marburg virus disease, Bundibugyo and Sudan virus diseases, early supportive care significantly improves survival.
This article was independently rewritten by ManyPress editorial AI from reporting originally published by WHO News.
